Acta Diabetologica

, Volume 28, Issue 1, pp 79–89 | Cite as

The effects of bilio-jejunal diversion on streptozotocin diabetes in the rat

  • Massimo Ermini
  • Egidio Iaconis
  • Andrea Mori
Original Contributions
Received:

Summary

Previous experimental indications that the internal biliary diversion (IBD), consisting in bilio-jejunal anastomosis, provokes an increase in glucose tolerance in healthy rats provide the basis for testing the hypothesis that this surgical procedure is capable of correcting pharmacologically-induced diabetes mellitus. To this object, the carbohydrate metabolism of an experimental group of six rats suffering from streptozotocin diabetes and treated with IBD (Lambert prosthetic choledoco-jejunostomy) was studied and comparated with that of three control groups: normal, diabetic without surgery and diabetic with sham-surgery. Carbohydrate metabolism, assessed during 60-day period by means of specific tests (basal and fasting blood glucose and insulin, glucose tolerance and insulin sensitivity), demonstrated that the IBD provokes a definitive remission, either total or partial, of the artificial diabetes mellitus. The results lead to the hypothetical explanation that diversion of bile flow from the duodenum to the proximal jejunum activates the ‘entero-insular axis’, specifically by potentiating the B-cell stimulating effect of the so-called enteric hormone ‘incretin’.

Key-words

Bilio-enteric diversion Choledoco-jejunostomy Diabetes treatment Entero-insular axis Experimental diabetes Incretin Streptozotocin diabetes 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barco P., Giannoni G.: Derivazione totale della bile e funzionalità pancreatica. (Studio sperimentale) —Clin. chir.10, 882–890, 1934.Google Scholar
  2. 2.
    Brown J. C., Otte S. C.: Gastrointestinal hormones and the control of insulin secretion— Diabetes27, 782–787, 1978.PubMedGoogle Scholar
  3. 3.
    Brown J. C., Otte S. C.: GIP and the entero-insular axis—Clin. Endocrinol. Metabol.8, 365–377, 1979.CrossRefGoogle Scholar
  4. 4.
    Creutzfeldt W.: Insulin-releasing factors on the gastrointestinal mucosa (incretin)—Gastroenterology67, 748–750, 1974.PubMedGoogle Scholar
  5. 5.
    Creutzfeldt W.: The incretin concept today—Diabetologia16, 75–85, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Creutzfeldt W., Ebert R.: New developments in incretine concept—Diabetologia28, 565–573, 1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Creutzfeldt W., Feurle G., Ketterez H.: Effect of gastrointestinal hormones on insulin and glucagon secretion—New Engl. J. Med.282, 1139–1141, 1970.PubMedCrossRefGoogle Scholar
  8. 8.
    Dupré J., Beck J. C.: Stimulation of release of insulin by an extract of intestinal mucosa— Diabetes15, 155–159, 1966.Google Scholar
  9. 9.
    Eloy R., Garaud J. C., Moody A., Jaeck D., Grenier J. F.: Jejunal factor stimulating insulin release in the isolated perfused canine pancreas and jejunum—Hormone metabol. Res.7, 461–467, 1975.CrossRefGoogle Scholar
  10. 10.
    Ermini M., Macaluso C., Masiello P.: Functional modifications of endocrine pancreas after internal biliary fistula (experimental research)—Acta diabetol. lat.15, 303–309, 1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Ermini M., Seccia M., Evangelista G.: Modifications of pancreatic islet tissue after internal biliary fistula (experimental research)—Acta diabetol. lat.12, 150–159, 1975.PubMedCrossRefGoogle Scholar
  12. 12.
    Lambert R.: Biliary fistula in the small intestine. In: Surgery of the Digestive System of the Rat. Charles C. Thomas Publ., Springfield/IL, 1965; pp. 142–149.Google Scholar
  13. 13.
    Leriche R., Joung A.: Essai sur le traitement chirurgical du diabète par la dérivation biliaire: documents expérimentaux et cliniques—Ann. Endocrinol.1, 3–10, 1939.Google Scholar
  14. 14.
    Loew E. R., Gray J. S., Ivy A. C.: Is a duodenal hormone involved in carbohydrate metabolism? —Amer. J. Physiol.129, 659–663, 1940.Google Scholar
  15. 15.
    Manfredini G., Ermini M., Scopsi L., Bonaguidi F., Ferrannini E.: Internal biliary diversion improves glucose tolerance in the rat—Amer. J. Physiol.249, G519-G527, 1985.PubMedGoogle Scholar
  16. 16.
    Moody A. J.: Insulin releasing polypeptides. In:Bajaj J. S. (Ed.): Diabetes. Excerpta Med. Intern. Congr. Ser. 413, Amsterdam, 1977; pp. 76–82.Google Scholar
  17. 17.
    Moody A. J., Markussen J., Schaich Fries A., Steenstrup C., Sundby F., Malaisse W., Malaisse-Lagae F.: The insulin releasing activities of extracts of pork intestine—Diabetologia6, 135–140, 1970.PubMedCrossRefGoogle Scholar
  18. 18.
    Rehfeld J. F.: Gastrointestinal hormones and insulin secretion—Scand. J. Gastroenterol.7, 289–292, 1972.CrossRefGoogle Scholar
  19. 19.
    Rey F., Mauron C., Bobbioni E., Jeanrenaud B., Mutt V., Felber J.-P.: Evidence for the presence of a neutral insulinotrophic peptide in the porcine duodenum—Acta endocrinol. (Kbh.)105, 398–406, 1984.Google Scholar
  20. 20.
    Reyes-Leal B., Castro A., Bernal E., Guardiola O.: Le role du duodénum dans l’insulino sécrétion—Sem. Hôp. Paris49, 1611–1617, 1973.PubMedGoogle Scholar
  21. 21.
    Szecowka J., Lins Pe., Efendic S.: Effects of cholecystokinin, gastric inhibitory polypeptide and secretin on insulin and glucagon secretion in rats—Endocrinology110, 1268–1272, 1982.PubMedGoogle Scholar
  22. 22.
    Togni G.: Contributo alla conoscenza dei rapporti tra deviazione biliare e diabete—Minerva med.2, 43–45, 1942.Google Scholar
  23. 23.
    Turner D. S., Etheridge L., Marks V., Brown J. C., Mutt V.: Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat—Diabetologia10, 459–463, 1974.PubMedCrossRefGoogle Scholar
  24. 24.
    Turner D. S., Shabaam A., Etheridge L., Marks V.: The effect of an intestinal polypeptide fraction on insulin release in the ratin vitro andin vivo—Endocrinology93, 1323–1328, 1973.PubMedCrossRefGoogle Scholar
  25. 25.
    Unger R. H., Eisentraut A. M.: Entero-insular axis—Arch. intern. Med.123, 261–266, 1969.PubMedCrossRefGoogle Scholar
  26. 26.
    Unger R. H., Ketterer H., Dupré J., Eisentraut A. M.: The effects of secretin, pancreozymin and gastrin on insulin and glucagon secretion in anesthetized dogs—J. clin. Invest.46, 630–645, 1967.PubMedGoogle Scholar
  27. 27.
    Verspohl E. J., Ammon H. P. T., Williams J. A., Goldfine I. D.: Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans— Diabetes35, 38–43, 1986.PubMedCrossRefGoogle Scholar

Copyright information

© Casa Editrice Il Ponte 1991

Authors and Affiliations

  • Massimo Ermini
    • 1
  • Egidio Iaconis
    • 1
  • Andrea Mori
    • 1
  1. 1.Istituto di Chirurgia Generale e Sperimentale dell’Università di PisaPisaItaly

Personalised recommendations